Novo Holdings A/S’s Apollo Endosurgery, Inc. APEN Stock Holding History

Novo Holdings A/S’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-274,472	Closed	-$1.28M	–	18
2017 Q3	$1.28M	Sell	274,472 -1,077,500	-80%	-$5.69M	0.17%	17
2017 Q2	$10.7M	Sell	1,351,972 -105,000	-7%	-$857K	1.28%	15
2017 Q1	$18.2M	Hold	1,456,972	–	–	1.94%	15
2016 Q4	$17.7M	Buy	+1,456,972	New	+$22.2M	1.69%	14

Other funds holding APEN

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Novo Holdings A/S's APEN Position: Q4 2017 in Review

Novo Holdings A/S sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2017, closing a stake of 274,472 shares — an estimated $1.28M sold.

Novo Holdings A/S first reported a position in APEN in Q4 2016 and held it in 4 quarters. The position peaked at $18.2M in Q1 2017. 23 funds tracked by Wall St. Rank hold APEN as of Q4 2017.

Novo Holdings A/S reported no remaining Apollo Endosurgery, Inc. position as of Q4 2017 after selling out during the quarter.
Novo Holdings A/S sold 274,472 Apollo Endosurgery, Inc. shares in Q4 2017, an estimated $1.28M.
Novo Holdings A/S first reported a position in Apollo Endosurgery, Inc. in Q4 2016 and held it in 4 quarters.
Novo Holdings A/S's Apollo Endosurgery, Inc. position peaked at $18.2M in Q1 2017.
23 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2017.

Based on Novo Holdings A/S's 13F filing for Q4 2017, filed 14 Feb 2018.